Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Autopedia Sukses Lestari Tbk (ASLC) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Autopedia Sukses Lestari TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Autopedia Sukses Lestari Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Autopedia Sukses Lestari Tbk trades at Rp62 (market cap 790.27B, 626.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 403.6K 24h volume). The key difference: Autopedia Sukses Lestari Tbk is the larger of the two by market cap, and Autopedia Sukses Lestari Tbk is more actively traded (626.1K versus 403.6K). Which is the better fit depends on your goals.

ASLCLABS
Market Cap
790.27B651.75B
Volume
626.1K403.6K
Lot
6.26K4.04K
Turnover
38.53M66.62M
Average Price
61.54165.07
Value
38.53M66.62M
Indicative Equilibrium Price
62165
Indicative Equilibrium Volume
22K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASLC
View details
LABS
View details

About Autopedia Sukses Lestari Tbk

PT Autopedia Sukses Lestari Tbk (formerly PT Adi Sarana Lelang) (the Company ) was established based on the notarial deed No. 93 of Dr. Irawan Soerodjo S.H., M.Si dated November 18, 2013. The Company started its commercial operations in 2014. The Company parent and ultimate parentcompany are PT Adi Sarana Armada Tbk and PT Adi Dinamika Investindo, respectively.

Read more on ASLC

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS